P&G Investments

Part
01
of one
Part
01

P&G Investments

Two additional products/services that P&G has acquired/invested in include the Neurobion products from Merck and a digital weight loss application for men.

MERCK'S NEUROBION PRODUCTS (Behavior modification)

  • Neurobion is part of Merck's consumer health business acquired by P&G in 2018.
  • Neurobion is a branded supplement that contains a mixture of three different B vitamins (B-1, B-6, and B-12), which helps enhance the nervous system and improve nerve, skin, and brain cell deficiencies.
  • As reported by Doc Prime, the Neurobion brand is prescribed to patients with mental disorders, Alzheimer’s disease, nerve damage, etc.

INVESTMENT TO DIGITAL WEIGHT LOSS APP FOR MEN (Weight loss/management)


HELPFUL FINDINGS:

Clearblue fertility and ovulation test Investment (with app-connectivity)

Smartphone-Connected Thermometer Investment (with app-connectivity)

Oral-B Genius X electric toothbrush Investment (with app-connectivity)

  • In February 2019, P&G announced its upcoming investment in an AI electric toothbrush in partnership with Oral-B Genius, a producer of consumer goods based in Cincinnati.
  • This electric toothbrush allows users to track the region of the mouth where they are brushing. It provides personalized data about areas that requires additional brushing.
  • According to P&G’s global brand director for Oral-B, Stephen Squire, "The Biometric Health Tracker concept is our idea of a 360-degree health platform designed to improve oral and overall health. It is not a finished product."
  • He goes on to state that the Biometric Health Tracker is a conception that will further facilitate pioneering work between Oral-B scientist, external researchers, and dental professionals and that the company seeks to explore the unlimited possibilities that connected oral-care devices can provide.
Sources
Sources